Search research articles
Contact Us
Filters
Showing results (91-100 of 163) with videos related to
Page
of 17
Sort By:
Nature Communications
|
May 27, 2017
Replicating viral vector platform exploits alarmin signals for potent CD8<sup>+</sup> T cell-mediated tumour immunotherapy
Sandra M Kallert, Stephanie Darbre, Weldy V Bonilla, et al.
BMC Cancer
|
October 8, 2014
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
Martin Sebastian, Alexandros Papachristofilou, Christian Weiss, et al.
Nature Immunology
|
March 14, 2019
Publisher Correction: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
Wan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Cancer Research
|
April 17, 2004
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance
Alfred Zippelius, Pascal Batard, Verena Rubio-Godoy, et al.
Nature Immunology
|
January 22, 2019
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
Wan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Immunity
|
September 29, 2022
High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity
Rodrigo Vazquez-Lombardi, Johanna S Jung, Fabrice S Schlatter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinoma
Silvia Guglietta, Anne Bärenwaldt, Anthony Sonrel, et al.
Cancer Immunology Research
|
June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells
Philipp Müller, Kea Martin, Sebastian Theurich, et al.
Breast Cancer Research : BCR
|
November 22, 2018
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer
Marcus Vetter, Julia Landin, Barbara Maria Szczerba, et al.
Cancer Immunity
|
May 20, 2004
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA
Danielle Liénard, Donata Rimoldi, Marie Marchand, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 163) with videos related to
Sort By:
Page
of 17
Nature Communications
|
May 27, 2017
Replicating viral vector platform exploits alarmin signals for potent CD8<sup>+</sup> T cell-mediated tumour immunotherapy
Sandra M Kallert, Stephanie Darbre, Weldy V Bonilla, et al.
BMC Cancer
|
October 8, 2014
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
Martin Sebastian, Alexandros Papachristofilou, Christian Weiss, et al.
Nature Immunology
|
March 14, 2019
Publisher Correction: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
Wan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Cancer Research
|
April 17, 2004
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance
Alfred Zippelius, Pascal Batard, Verena Rubio-Godoy, et al.
Nature Immunology
|
January 22, 2019
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
Wan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Immunity
|
September 29, 2022
High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity
Rodrigo Vazquez-Lombardi, Johanna S Jung, Fabrice S Schlatter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinoma
Silvia Guglietta, Anne Bärenwaldt, Anthony Sonrel, et al.
Cancer Immunology Research
|
June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells
Philipp Müller, Kea Martin, Sebastian Theurich, et al.
Breast Cancer Research : BCR
|
November 22, 2018
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer
Marcus Vetter, Julia Landin, Barbara Maria Szczerba, et al.
Cancer Immunity
|
May 20, 2004
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA
Danielle Liénard, Donata Rimoldi, Marie Marchand, et al.
Page
of 17